As of 2025-10-23, the Relative Valuation of Jounce Therapeutics Inc (JNCE) is (1.74) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.88 USD, the upside of Jounce Therapeutics Inc based on Relative Valuation is -192.6%.
The range of the Relative Valuation is (1.97) - (1.22) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.8x - 1.3x | 1.0x |
| Forward P/E multiples | 2.0x - 3.1x | 2.6x |
| Fair Price | (1.97) - (1.22) | (1.74) |
| Upside | -205.0% - -164.8% | -192.6% |
| Date | P/E |